实用肿瘤学杂志 ›› 2013, Vol. 27 ›› Issue (1): 74-76.doi: 10.3969/j.issn.1002-3070.2013.01.016

• 综述 • 上一篇    下一篇

肝癌氩氦刀治疗效果评价展望

高金生综述, 陆海波审校   

  1. 哈尔滨医科大学附属第三医院内八科(哈尔滨 150081)
  • 收稿日期:2012-10-31 出版日期:2013-02-28 发布日期:2013-03-07
  • 通讯作者: 陆海波, E-mail:lu_haibo200@126.com
  • 作者简介:高金生, 男, (1979-), 硕士研究生, 从事微创及消化道肿瘤研究
  • 基金资助:
    黑龙江省自然科学基金(D2007-57);哈尔滨市科技创新基金(RC2009QN004156)

Treatment effectiveness evaluation of argon-helium cryoablation in liver cancer

GAO Jinsheng, LU Haibo   

  1. Department of Internal Medicine, The Third Affiliated Hospital of Harbin Medical University, Harbin 150040, China
  • Received:2012-10-31 Online:2013-02-28 Published:2013-03-07

摘要: 随着肝癌发生机制研究的深入及肿瘤治疗技术的进步, 对肝癌的治疗也有了一定的进展。近年来, 氩氦刀治疗肝癌作为一种新的治疗方法, 在临床上逐渐得到推广应用。然而肝癌氩氦刀治疗后, 如何经济又实用的判断其治疗疗效, 一直是困扰临床应用的实际问题。本文拟就国内外相关研究进展进行探讨。

Abstract: As the evolutions of pathogenesis and oncotherapy on oncology, great progression has been made in treating with primary hepatocellular carcinoma(HCC).Recent years, argon-helium cryoablation, which is a new therapeutic method, has been extensivly used in clinical.However, after treating primary hepatocellular carcinoma by argon-helium cryoablation, how to evaluate effectiveness economically and practically is still a puzzle in clinical application.In this review, we will approach the related research from home and aboard.

中图分类号: